How can CoverMyMeds improve its electronic prior authorization process to reduce approval times for patients?

Introduction

I'm excited to dive into how we can improve CoverMyMeds' electronic prior authorization process to reduce approval times for patients. This is a critical challenge in healthcare, directly impacting patient care and satisfaction. I'll approach this by examining user segments, analyzing pain points, generating solutions, and proposing metrics for success. Let's begin with some clarifying questions to ensure we're aligned on the problem space.

Step 1

Clarifying Questions

• Looking at the product context, I'm thinking about the current state of the electronic prior authorization (ePA) process. Could you share some insights on the average approval time right now and what specific bottlenecks we've identified in the workflow?

Why it matters: This helps us pinpoint where to focus our improvement efforts. Expected answer: Average approval time is 48-72 hours, with bottlenecks in provider response time and payer processing. Impact on approach: Would prioritize solutions targeting these specific areas of delay.

• Considering user behavior, I'm curious about the adoption rate of the ePA process among healthcare providers. What percentage of providers are currently using our electronic system versus traditional methods, and what's driving or hindering adoption?

Why it matters: Determines if we need to focus on increasing adoption or improving the existing process. Expected answer: 60% adoption rate, with ease of use and integration with existing systems as key factors. Impact on approach: Would influence whether we prioritize onboarding improvements or core process enhancements.

• From a product lifecycle perspective, I'm wondering about our current market position and primary competitors. How does our approval time compare to industry standards, and what unique features set us apart?

Why it matters: Helps identify our competitive edge and areas for differentiation. Expected answer: We're a market leader with approval times slightly better than average, known for our integration capabilities. Impact on approach: Would focus on leveraging our strengths while addressing any lagging areas.

• Thinking about company alignment, I'd like to understand the key performance indicators (KPIs) driving this improvement initiative. Are we primarily focused on reducing approval times, increasing patient satisfaction, or expanding market share?

Why it matters: Ensures our solutions align with broader company objectives. Expected answer: Primary focus is on reducing approval times, with patient satisfaction as a close secondary goal. Impact on approach: Would prioritize speed-focused solutions that also enhance the patient experience.